) has been revised to $8.92 / share. This is a decrease of 27.08% from the prior estimate of $12.24 dated November 14, 2025. The price target is an average of many targets provided by analysts. The ...

Fintel reports that on December 3, 2025, Roth Capital initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. As of November 17, 2025, the average one-year price target for ...

An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models. The consensus rating for Microbot Medical is "Strong ...

We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Microbot Medical Inc (NASDAQ:MBOT) stands ...